51 related articles for article (PubMed ID: 16987492)
1. N-terminal acylation of the SV40 nuclear localization signal peptide enhances its oligonucleotide binding and membrane translocation efficiencies.
Laczkó I; Váró G; Bottka S; Bálint Z; Illyés E; Vass E; Bertrand JR; Malvy C; Hollósi M
Arch Biochem Biophys; 2006 Oct; 454(2):146-54. PubMed ID: 16987492
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
Lev N; Shai Y
J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and studies on cell-penetrating peptides.
Bertrand JR; Malvy C; Auguste T; Tóth GK; Kiss-Ivánkovits O; Illyés E; Hollósi M; Bottka S; Laczkó I
Bioconjug Chem; 2009 Jul; 20(7):1307-14. PubMed ID: 19552459
[TBL] [Abstract][Full Text] [Related]
4. Complex formation and vectorization of a phosphorothioate oligonucleotide with an amphipathic leucine- and lysine-rich peptide: study at molecular and cellular levels.
Boukhalfa-Heniche FZ; Hernández B; Gaillard S; Coïc YM; Huynh-Dinh T; Lecouvey M; Seksek O; Ghomi M
Biopolymers; 2004 Apr; 73(6):727-34. PubMed ID: 15048776
[TBL] [Abstract][Full Text] [Related]
5. A novel 11-residual peptaibol-derived carrier peptide for in vitro oligodeoxynucleotide delivery into cell.
Wada SI; Tanaka R
Bioorg Med Chem Lett; 2004 May; 14(10):2563-6. PubMed ID: 15109652
[TBL] [Abstract][Full Text] [Related]
6. In vivo potentialities of EWS-Fli-1 targeted antisense oligonucleotides-nanospheres complexes.
Maksimenko A; Polard V; Villemeur M; Elhamess H; Couvreur P; Bertrand JR; Aboubakar M; Gottikh M; Malvy C
Ann N Y Acad Sci; 2005 Nov; 1058():52-61. PubMed ID: 16394125
[TBL] [Abstract][Full Text] [Related]
7. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films.
Zhang Z; Cao X; Zhao X; Holt CM; Lewis AL; Lu JR
J Control Release; 2008 Aug; 130(1):69-76. PubMed ID: 18562037
[TBL] [Abstract][Full Text] [Related]
9. EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice.
Lambert G; Bertrand JR; Fattal E; Subra F; Pinto-Alphandary H; Malvy C; Auclair C; Couvreur P
Biochem Biophys Res Commun; 2000 Dec; 279(2):401-6. PubMed ID: 11118299
[TBL] [Abstract][Full Text] [Related]
10. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.
Arvand A; Welford SM; Teitell MA; Denny CT
Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376
[TBL] [Abstract][Full Text] [Related]
11. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties.
Chaloin L; Vidal P; Lory P; Méry J; Lautredou N; Divita G; Heitz F
Biochem Biophys Res Commun; 1998 Feb; 243(2):601-8. PubMed ID: 9480855
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C acylation by palmitoyl coenzyme A facilitates its translocation to membranes.
Ford DA; Horner CC; Gross RW
Biochemistry; 1998 Aug; 37(34):11953-61. PubMed ID: 9718320
[TBL] [Abstract][Full Text] [Related]
13. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA.
Brandén LJ; Mohamed AJ; Smith CI
Nat Biotechnol; 1999 Aug; 17(8):784-7. PubMed ID: 10429244
[TBL] [Abstract][Full Text] [Related]
14. Novel, cell-penetrating molecular transporters with flexible backbones and permanently charged side-chains.
Bodor N; Tóth-Sarudy E; Holm T; Pallagi I; Vass E; Buchwald P; Langel U
J Pharm Pharmacol; 2007 Aug; 59(8):1065-76. PubMed ID: 17725848
[TBL] [Abstract][Full Text] [Related]
15. Novel cationic transport agents for oligonucleotide delivery into primary leukemic cells.
Králová J; Dvorák M; Král V
J Med Chem; 2003 May; 46(11):2049-56. PubMed ID: 12747777
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
18. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
Seebach D; Beck AK; Bierbaum DJ
Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
[TBL] [Abstract][Full Text] [Related]
19. c-Fos antisense oligodeoxynucleotide offsets behavioral nociceptive responses and both up-regulations of c-Fos protein and dynorphin a (1-8) in dorsal horn: a study using the formalin test in rats.
Zhang Y; Qiao JT; Dafny N
Int J Neurosci; 2005 Jul; 115(7):935-48. PubMed ID: 16051541
[TBL] [Abstract][Full Text] [Related]
20. Membrane translocation mechanism of the antimicrobial peptide buforin 2.
Kobayashi S; Chikushi A; Tougu S; Imura Y; Nishida M; Yano Y; Matsuzaki K
Biochemistry; 2004 Dec; 43(49):15610-6. PubMed ID: 15581374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
